Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Cancer Clinical Trials

38 recruiting trials for Cancer. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
38
Total Trials
38
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT04981119

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Objective: To collect information on how often a solid tumor cancer might lose the Human Leukocyte Antigen (HLA) by next generation sequencing and perform apheresis to collect...

Sponsor: A2 Biotherapeutics Inc.Enrolling: 20016 locations
RECRUITINGNCT06096623

The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment

This study assesses the feasibility and acceptability of a brief electronic patient-reported outcome (ePRO) tool that allows patients to self-identify impending delays. The risk...

Sponsor: UNC Lineberger Comprehensive Cancer CenterEnrolling: 2401 location
RECRUITINGPhase 1NCT05544240

Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors

SV-101 is intended to overcome the complex and multifactorial nature of the mechanisms mediating tumor immune evasion, by the use of a combination of therapeutic agents that...

Sponsor: Williams Cancer FoundationEnrolling: 201 location
RECRUITINGNCT07068477

Adaptation of a Values Assessment Tool

The primary purpose of this study is to evaluate the effect of values assessment tool on patient and caregiver perception of decisional conflict, and communication with their...

Sponsor: UNC Lineberger Comprehensive Cancer CenterEnrolling: 401 location
RECRUITINGPhase 1 / Phase 2NCT04787042

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

This is a multiphase, multicenter study, which includes a Phase 1a open-label, dose escalation monotherapy study of ST-067 given as an SC injection with or without obinutuzumab...

Sponsor: Simcha IL-18, Inc.Enrolling: 3166 locations
RECRUITINGPhase 1 / Phase 2NCT06051695

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid...

The goal of this study is to test autologous logic-gated Tmod™ CAR T-cell products in subjects with solid tumors including colorectal cancer (CRC), pancreatic cancer (PANC),...

Sponsor: A2 Biotherapeutics Inc.Enrolling: 47412 locations
RECRUITINGNCT05635266

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and...

Sponsor: Sanguine BiosciencesEnrolling: 200001 location
RECRUITINGNCT07389512

Pharmaceutical Management in Targeted Radioligand Therapy

Targeted Radionuclide Therapy (TRT) is a treatment modality used in nuclear medicine to target cancer cells while preserving surrounding healthy tissues. This approach is based on...

Sponsor: Hospices Civils de LyonEnrolling: 6003 locations
RECRUITINGPhase 1NCT07424547

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

The goal of this clinical trial is to learn if investigational drug called SYS6043 works in adults with advanced or metastatic solid tumors that have spread or cannot be treated...

Sponsor: Conjupro Biotherapeutics, Inc.Enrolling: 3865 locations
RECRUITINGNCT07327489

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies

This study will collect tumor specimens with correlated clinical and demographic data from patients who are undergoing a biopsy or similar procedure to obtain tumor tissue as a...

Sponsor: ElephasEnrolling: 20008 locations
RECRUITINGNCT05142033

Avera Cancer Sequencing and Analytics Protocol (ASAP)

The purpose of this study is to characterize the breadth of molecular features present in participants receiving care within a large, integrated, community-based healthcare...

Sponsor: Avera McKennan Hospital & University Health CenterEnrolling: 250006 locations
RECRUITINGNCT07042243

The Florida ASCENT Study

The goal of this clinical trial is to adapt, implement, and evaluate MyCarePulse and ASCENT patient navigator to overcome barriers to care among patients with cancer. The main...

Sponsor: University of FloridaEnrolling: 1001 location
RECRUITINGNCT02333604

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

The Cancer Experience Registry®: An Online Survey Research Study to Understand the Experiences of Those Impacted By a Cancer Diagnosis. The Registry is a web-based platform to...

Sponsor: Cancer Support Community, Research and Training Institute, PhiladelphiaEnrolling: 150001 location
RECRUITINGNCT05297734

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC)...

Sponsor: Stanford UniversityEnrolling: 299617 locations
RECRUITINGPhase 1NCT07317505

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

The goal of this clinical trial is to test JMT108, a type of drug called a bispecific antibody in adult patients with locally advanced or metastatic solid tumors. The main...

Sponsor: Conjupro Biotherapeutics, Inc.Enrolling: 2703 locations
RECRUITINGNCT05315895

The Dampness Syndrome of Chinese Medicine Cohort Study

The researchers plain to build a large-scale, longitudinal, prospective cohort characterized by TCM dampness syndrome. With the biobank of this cohort the investigators want to...

Sponsor: Guangzhou University of Traditional Chinese MedicineEnrolling: 1000001 location
RECRUITINGPhase 1 / Phase 2NCT03213002

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

The purpose of this study is to evaluate the safety and efficacy of administering the medication capecitabine along with temozolomide when you start your monthly regimen of oral...

Sponsor: Northwell HealthEnrolling: 671 location
RECRUITINGNCT05318196

Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

Managing patients with renal failure requires an understanding of the molecular mechanisms that lead to its occurrence (i.e. upstream of the disease), its worsening and its...

Sponsor: University Hospital, ToulouseEnrolling: 50001 location
RECRUITINGNCT05398783

A Natural History Study of Metabolic Sizing in Health and Disease

Background: Scientists have long used simple measures (such as height and weight) to estimate how much a person s body uses food (calories) as energy, as commonly called the...

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrolling: 20001 location
RECRUITINGNCT03225586

Prospective Urban Rural Epidemiology Study

To examine the impact of health determinants at the individual (e.g. health related behaviors) and societal level (e.g. environmental factors, health related policy, quality of...

Sponsor: Population Health Research InstituteEnrolling: 20000020 locations
RECRUITINGPhase 1 / Phase 2NCT06682793

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid...

The goal of this study is to test A2B395, an allogeneic logic-gated Tmod™ CAR T-cell product in subjects with solid tumors including colorectal cancer (CRC), non-small cell lung...

Sponsor: A2 Biotherapeutics Inc.Enrolling: 24010 locations
RECRUITINGNCT06909643

Development and Prospective Validation of a Multimodal Fusion Artificial Intelligence Model for Predicting the Efficacy...

This study is a multi-center observational study without interventions, including the construction of an AI diagnostic model and retrospective testing of a multi-center cohort....

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityEnrolling: 5501 location
RECRUITINGPhase 2NCT06458036

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical...

Sponsor: Children's Hospital of PhiladelphiaEnrolling: 132 locations
RECRUITINGPhase 2NCT05783323

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical...

Sponsor: Children's Hospital of PhiladelphiaEnrolling: 135 locations
RECRUITINGNCT05347524

Detection of Peritoneal Metastasis of Gastric Cancer by Liquid Biopsy in Peripheral Blood: A Prospective Study

This study is a prospective, multi-omics, observational study aimed at detecting peritoneal metastasis of gastric cancer by combined assays for methylation of cell-free DNA...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 3841 location
RECRUITINGNCT06371768

Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer...

The purpose of this study is to determine the effectiveness of a digital health program called AYA STEPS, which is designed to help adolescent and young adult (AYA) cancer...

Sponsor: Duke UniversityEnrolling: 2601 location
RECRUITINGPhase 2NCT06790082

The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma

Seventy (N=70) patients with suspected pleural mesothelioma (PM) lesions referred to pleural biopsy will be recruited, and undergo an additional FAPI PET/CT at primary staging....

Sponsor: Aalborg University HospitalEnrolling: 701 location
RECRUITINGNCT06455384

The Genetics Navigator: Evaluating a Digital Platform for Genomics Health Services

Genetic testing (GT) (including targeted panels, exome and genome sequencing) is increasingly being used for patient care as it improves diagnosis and health outcomes. In spite of...

Sponsor: Unity Health TorontoEnrolling: 1703 locations
RECRUITINGNCT05023785

The HIMALAYAS Trial and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A...

Pediatric, adolescent and young adult cancer survivors (PAYA-CS) are at higher risk of cardiovascular (CV) morbidity and mortality. This is a consequence of prior cancer-related...

Sponsor: University Health Network, TorontoEnrolling: 3361 location
RECRUITINGNCT06519292

Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer

Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment and are now approved for various types of cancer. The most common side effects of ICI are immune-related...

Sponsor: Hanneke W. M. van LaarhovenEnrolling: 2141 location
RECRUITINGNCT06451003

Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery

While blood clots after major cancer surgery are common and harmful to patients, the medications to decrease blood clot risk are seldom used after patients leave the hospital...

Sponsor: Medical University of South CarolinaEnrolling: 301 location
RECRUITINGPhase 4NCT06603870

Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis

This trial seeks to evaluate a management strategy after the acute treatment duration (≥ 3 months of therapeutic anticoagulation) for patients with cancer and catheter-related...

Sponsor: Ottawa Hospital Research InstituteEnrolling: 3301 location
RECRUITINGNCT06930729

Optimizing Care for Cancer Survivors With Depression: Project 3

The purpose of this research study is to evaluate different depression treatment approaches among cancer survivors. A cancer survivor is defined as anyone who is living and has...

Sponsor: Medical University of South CarolinaEnrolling: 451 location
RECRUITINGNCT05302375

Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2)

The purpose of this study is to determine the extent to which an online pathway to depression treatment (iPath\*D) is acceptable and usable to patients receiving cancer treatment...

Sponsor: Dartmouth-Hitchcock Medical CenterEnrolling: 301 location
RECRUITINGNCT04656496

NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors

Pediatric cancer survivors are at an increased risk of excessive weight gain and reduced exercise behaviors with the potential for this risk to worsen over time. With over 80% of...

Sponsor: University of South FloridaEnrolling: 52010 locations
RECRUITINGNCT03952624

Patient-Centered Assessment of Symptoms and Outcomes

Background: The cause of fatigue is not well understood. It can be felt differently by different people. Some people think there are different types of fatigue, with different...

Sponsor: National Center for Complementary and Integrative Health (NCCIH)Enrolling: 6921 location
RECRUITINGNCT07126587

Healthy Living Anson Study

The goal of this randomized delayed control intervention research study is to see if participants who receive education and healthy prepared meals improve the quality of their...

Sponsor: University of North Carolina, Chapel HillEnrolling: 1201 location
RECRUITINGNCT05384509

(COVID-19) Longitudinal Neutralizing Antibody Titers in Cancer Patients Receiving Different Anti-caner Therapies

Patients with cancer are considered vulnerable to severe acute respiratory syndrome coronavirus 2 infection and have been prioritized in the vaccination process in several...

Sponsor: Chang Gung Memorial HospitalEnrolling: 3201 location